Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.11M Sell
23,139
-3,270
-12% -$167K 0.03% 402
2026
Q2
$1.38M Sell
26,409
-156
-0.6% -$8.25K 0.04% 380
2026
Q1
$1.35M Buy
26,565
+1,286
+5% +$69.7K 0.04% 387
2025
Q4
$1.24M Sell
25,279
-61,951
-71% -$2.89M 0.05% 316
2025
Q3
$3.76M Buy
87,230
+2,555
+3% +$100K 0.13% 161
2025
Q2
$3.19M Sell
84,675
-4,170
-5% -$159K 0.13% 162
2025
Q1
$3.44M Buy
+88,845
New +$3.25M 0.16% 136

Other funds holding GSK

VestGen Advisors's GSK Position: Q3 2026 in Review

VestGen Advisors reduced its GSK (GSK) stake by 12% in Q3 2026, selling an estimated $167K and leaving 23,139 shares worth $1.11M. The position accounts for 0.03% of the portfolio, ranked #402.

VestGen Advisors first reported a position in GSK in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.76M in Q3 2025. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • VestGen Advisors held 23,139 shares of GSK worth $1.11M as of Q3 2026.
  • VestGen Advisors sold 3,270 GSK shares in Q3 2026, an estimated $167K.
  • GSK made up 0.03% of VestGen Advisors's portfolio in Q3 2026, its #402 holding.
  • VestGen Advisors first reported a position in GSK in Q1 2025 and has held it in 7 quarters since.
  • VestGen Advisors's GSK position peaked at $3.76M in Q3 2025.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on VestGen Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.